Bicycle therapeutics to participate in the morgan stanley 20th annual global healthcare conference

Cambridge, england, & boston--(business wire)--bicycle therapeutics plc (nasdaq: bcyc), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (bicycle®) technology, today announced that management will participate in a fireside chat at the morgan stanley 20th annual global healthcare conference on september 13th, 2022 at 10:00 a.m. et. a live webcast of the fireside chat will be accessible in the investors and media section o
BCYC Ratings Summary
BCYC Quant Ranking